DTGCX
Price
$38.39
Change
+$0.26 (+0.68%)
Updated
Jun 12 closing price
Net Assets
567.66M
JATNX
Price
$87.52
Change
+$3.68 (+4.39%)
Updated
Jun 11 closing price
Net Assets
10.84B
Interact to see
Advertisement

DTGCX vs JATNX

Header iconDTGCX vs JATNX Comparison
Open Charts DTGCX vs JATNXBanner chart's image
DTGCX vs JATNX Comparison Chart in %
View a ticker or compare two or three
VS
DTGCX vs. JATNX commentary
Jun 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DTGCX is a Hold and JATNX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JATNX has more cash in the bank: 10.8B vs. DTGCX (568M). DTGCX (0.00) and JATNX (0.00) have matching dividends . DTGCX was incepted earlier than JATNX: DTGCX (27 years) vs JATNX (9 years). DTGCX (1.97) is less costly to investors than JATNX (0.69). JATNX is a more actively managed with annual turnover of: 49.00 vs. DTGCX (33.84). DTGCX has a lower initial minimum investment than JATNX: DTGCX (1000) vs JATNX (1000000). JATNX annual gain was more profitable for investors over the last year : 28.93 vs. DTGCX (17.65). JATNX return over 5 years is better than : 47.76 vs. DTGCX (-6.93).
DTGCXJATNXDTGCX / JATNX
Total Expense Ratio1.970.69286%
Annual Report Gross Expense Ratio1.970.69286%
Fund Existence27 years9 years-
Gain YTD27.88126.657105%
Front LoadN/AN/A-
Min. Initial Investment100010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets568M10.8B5%
Annual Yield % from dividends0.000.00-
Returns for 1 year17.6528.9361%
Returns for 3 years65.9086.8976%
Returns for 5 years-6.9347.76-15%
Returns for 10 years16.76N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WEN6.79N/A
N/A
Wendy's Company
OACC10.66N/A
N/A
Oaktree Acquisition Corp. III Life Sciences
BLIV2.39N/A
N/A
BeLive Holdings
VRTX444.92-0.12
-0.03%
Vertex Pharmaceuticals
MIRM99.35-0.20
-0.20%
Mirum Pharmaceuticals